Global Antimicrobial Textile Market Size, Trends & Growth Opportunity, By Active Agent (Synthetic Organic Agents, Metal & Metallic Salts, Bio-based Agents, Others), By Fibers (Cotton, Polyester, Polyamide, Others), By Region and Forecast till 2027
Report ID : QR1001268 | Industries : Consumer Goods | Published On :November 2021 | Page Count : 243Global Antimicrobial Textile Market
The global Antimicrobial Textile market was valued at USD 10800 million in 2020 which expected to reach USD 14700 million by 2027 at a CAGR 6.5% from 2020-2027.
A Antimicrobial Textile is a structure that protects a microwave antenna. It is made of materials that do not interfere with the transmission of electromagnetic signals. Furthermore, it is naturally waterproof. Antimicrobial Textiles are used in aircraft to relay communications more efficiently.
Market Drivers
Antimicrobial textiles are increasingly being used in medical textiles.
Know more about this report: request for sample pages
Antimicrobial agents are used to either kill or inhibit the growth of germs. Antimicrobial fibers are fabrics that have had antimicrobial chemicals added to the surface or within the fibers. Antimicrobial compounds are added to the fiber during the spinning or extrusion process, coupled with dyes or pigments, or applied as a finishing procedure.
Market Restraints
Raw material price volatility.
The prices of raw materials and energy utilized in the production of antimicrobial fabrics are fluctuating. The prices of these commodities have a direct impact on the value chain units, which comprise procurement and operating costs. Companies' profit margins are also affected by sudden price increases or decreases. The price and availability of raw materials have a significant impact on the ultimate pricing of antimicrobial textiles.
Impact of COVID-19
The COVID-19 pandemic had a negligible impact on the antimicrobial fabrics industry, resulting in a modest reduction in CAGR. During COVID -19, the market has been affected by lower raw material output, supply chain disruptions, and impeded trade movements. The pandemic had an impact on end-use businesses including as food, beverage, retail, and home and personal care.
Market Segmentation
The Global Antimicrobial Textile Market is segmented into Active Agent, Fibers, Distribution Channel and Growing System. By Active Agent such as Synthetic Organic Agents, Metal & Metallic Salts, Bio-based Agents, Others. Further, market is segmented into By Fibers such as Cotton, Polyester, Polyamide, Others.
Regional Analysis
Global Antimicrobial Textile Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the antimicrobial textiles industry. Because of the limitations in current medication therapy, treatment, and management of orthopedic, cardiovascular, ophthalmic, neurological, and a variety of other chronic conditions.
Key Players
Various key players are listed in this report such as Milliken & Company, PurThread Technologies, Trevira GmbH, Thai Acrylic Fiber Co. Ltd. and Vestagen Protective Technologies, Inc., Sanitized AG, BASF SE, Herculite, Smith & Nephew
Market Taxonomy
By Active Agent
- Synthetic Organic Agents
- Metal & Metallic Salts
- Bio-based Agents
- Others
By Fibers
- Cotton
- Polyester
- Polyamide
- Others
By Region
- North America
- Latin America
- Europe
- China
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Antimicrobial Textile Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Active Pharmaceutical Ingredient (API) Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Active Pharmaceutical Ingredient (API) Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Active Pharmaceutical Ingredient (API) Market, By Business Mode
5.1 Y-o-Y Growth Comparison, By Business Mode
5.2 Active Pharmaceutical Ingredient (API) Market Share Analysis, By Business Mode
5.3 Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Business Mode
5.3.1 Captive API
5.3.2 Merchant API
6 Active Pharmaceutical Ingredient (API) Market, By Synthesis Type
6.1 Y-o-Y Growth Comparison, By Synthesis Type
6.2 Active Pharmaceutical Ingredient (API) Market Share Analysis, By Synthesis Type
6.3 Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Synthesis Type
6.3.1 Synthetic
6.3.2 Biotech
7 Active Pharmaceutical Ingredient (API) Market, By Type of Drug
7.1 Y-o-Y Growth Comparison, By Type of Drug
7.2 Active Pharmaceutical Ingredient (API) Market Share Analysis, By Type of Drug
7.3 Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Type of Drug
7.3.1 Generic
7.3.2 Branded
8 Active Pharmaceutical Ingredient (API) Market, By Application
8.1 Y-o-Y Growth Comparison, By Application
8.2 Active Pharmaceutical Ingredient (API) Market Share Analysis, By Application
8.3 Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Application
8.3.1 Cardiology
8.3.2 Pulmonology
8.3.3 Oncology
8.3.4 Ophthalmology
8.3.5 Neurology
8.3.6 Orthopedic
8.3.7 Other Applications
9 Active Pharmaceutical Ingredient (API) Market, By Region
9.1 Active Pharmaceutical Ingredient (API) Market Share Analysis, By Region
9.2 Active Pharmaceutical Ingredient (API) Market Share Analysis, By Region
9.3 Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Region
10 North America Active Pharmaceutical Ingredient (API) Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 North America Active Pharmaceutical Ingredient (API) Market Share Analysis, By Business Mode
10.3 North America Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Synthesis Type
10.4 North America Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Type of Drug
10.4 North America Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Application
10.5 North America Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Country
10.5.1 U.S.
10.5.2 Canada
10.5.3 Mexico
11 Europe Active Pharmaceutical Ingredient (API) Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Europe Active Pharmaceutical Ingredient (API) Market Share Analysis, By Business Mode
11.3 Europe Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Synthesis Type
11.4 Europe Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Type of Drug
11.4 Europe Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Application
11.5 Europe Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Country
11.5.1 Germany
11.5.2 France
11.5.3 UK
11.54. Rest of Europe
12 Asia Pacific Active Pharmaceutical Ingredient (API) Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Asia Pacific Active Pharmaceutical Ingredient (API) Market Share Analysis, By Business Mode
12.3 Asia Pacific Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Synthesis Type
12.4 Asia Pacific Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Type of Drug
12.4 Asia Pacific Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Application
12.5 Asia Pacific Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Country
12.5.1 China
12.5.2 Japan
12.5.3 India
12.5.4. Rest of Asia Pacific
13 Latin America Active Pharmaceutical Ingredient (API) Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Latin America Active Pharmaceutical Ingredient (API) Market Share Analysis, By Business Mode
13.3 Latin America Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Synthesis Type
13.4 Latin America Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Type of Drug
13.4 Latin America Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Application
13.5 Latin America Active Pharmaceutical Ingredient (API) Market Size and Forecast, Country
13.5.1. Brazil
13.5.2. Rest of Latin America
14 Middle East Active Pharmaceutical Ingredient (API) Market Analysis and Forecast (2021-2027)
14.1 Introduction
14.2 Middle East Active Pharmaceutical Ingredient (API) Market Share Analysis, By Business Mode
14.3 Middle East Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Synthesis Type
14.4 Middle East Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Type of Drug
14.4 Middle East Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Application
14.5 Middle East Active Pharmaceutical Ingredient (API) Market Size and Forecast, By Country
14.5.1. Saudi Arabia
14.5.2. UAE
14.5.3. Egypt
14.5.4. Kuwait
14.5.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Aurobindo Pharma Limited
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Sun Pharmaceutical Industries Ltd.
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Dr. Reddy’s Laboratories Ltd.
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Boehringer Ingelheim International GmbH
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Cipla Inc.
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 F. Hoffmann-La Roche AG
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Pfizer Inc.
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Merck & Co.
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Teva Pharmaceutical Industries Ltd.
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies